Victory Capital Management
NVAX icon

Victory Capital Management’s Novavax NVAX Stock Holding History

Victory Capital Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Sell
18,049
-89
-0.5% -$798 ﹤0.01% 2283
2026
Q1 		$148K Sell
18,138
-9,117
-33% -$82.6K ﹤0.01% 2236
2025
Q4 		$183K Sell
27,255
-17,177
-39% -$129K ﹤0.01% 2216
2025
Q3 		$385K Sell
44,432
-555
-1% -$4.32K ﹤0.01% 2100
2025
Q2 		$283K Buy
44,987
+27,289
+154% +$181K ﹤0.01% 2173
2025
Q1 		$113K Sell
17,698
-1,230
-6% -$10.2K ﹤0.01% 2299
2024
Q4 		$152K Sell
18,928
-364
-2% -$3.51K ﹤0.01% 2279
2024
Q3 		$244K Buy
19,292
+2,072
+12% +$26.8K ﹤0.01% 2178
2024
Q2 		$218K Sell
17,220
-128
-0.7% -$1.29K ﹤0.01% 2182
2024
Q1 		$82.9K Buy
17,348
+2,257
+15% +$10.5K ﹤0.01% 2322
2023
Q4 		$72.4K Buy
+15,091
New +$92.4K ﹤0.01% 2390
2022
Q3 		– Sell
-10,319
Closed -$531K – 2749
2022
Q2 		$531K Sell
10,319
-7,415
-42% -$384K ﹤0.01% 2028
2022
Q1 		$799K Sell
17,734
-16,505
-48% -$1.47M ﹤0.01% 1920
2021
Q4 		$4.9M Sell
34,239
-919
-3% -$158K ﹤0.01% 1331
2021
Q3 		$7.29M Sell
35,158
-26,167
-43% -$5.77M 0.01% 1198
2021
Q2 		$13M Buy
61,325
+10,799
+21% +$1.98M 0.01% 1045
2021
Q1 		$9.16M Buy
50,526
+29,970
+146% +$5.97M 0.01% 1166
2020
Q4 		$2.29M Buy
20,556
+2,638
+15% +$280K ﹤0.01% 1477
2020
Q3 		$1.94M Sell
17,918
-13,715
-43% -$1.67M ﹤0.01% 1453
2020
Q2 		$2.64M Buy
31,633
+23,078
+270% +$883K ﹤0.01% 1349
2020
Q1 		$116K Buy
+8,555
New +$72.4K ﹤0.01% 2285
2019
Q4 		– Sell
-3,973
Closed -$20K – 3043
2019
Q3 		$20K Buy
+3,973
New +$21.7K ﹤0.01% 3044
2016
Q3 		– Sell
-195
Closed -$28K – 1815
2016
Q2 		$28K Buy
195
+8
+4% +$917 ﹤0.01% 1580
2016
Q1 		$19K Buy
187
+14
+8% +$1.5K ﹤0.01% 1614
2015
Q4 		$29K Buy
173
+10
+6% +$1.54K ﹤0.01% 1622
2015
Q3 		$23K Buy
163
+12
+8% +$2.69K ﹤0.01% 1578
2015
Q2 		$34K Buy
+151
New +$26.5K ﹤0.01% 1563

Other funds holding NVAX

SCM
Shah Capital Management Raleigh, North Carolina $526M AUM 46.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Coatue Management
Coatue Management New York $48.6B AUM 94.27% 1-Year Est. Return

Victory Capital Management's NVAX Position: Q2 2026 in Review

Victory Capital Management reduced its Novavax (NVAX) stake by 0.49% in Q2 2026, selling an estimated $798 and leaving 18,049 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #2283.

Victory Capital Management first reported a position in NVAX in Q2 2015 and has held it in 27 quarters since. The position peaked at $13M in Q2 2021. 267 funds tracked by Wall St. Rank hold NVAX as of Q2 2026.

  • Victory Capital Management held 18,049 shares of Novavax worth $170K as of Q2 2026.
  • Victory Capital Management sold 89 Novavax shares in Q2 2026, an estimated $798.
  • Novavax made up ﹤0.01% of Victory Capital Management's portfolio in Q2 2026, its #2283 holding.
  • Victory Capital Management first reported a position in Novavax in Q2 2015 and has held it in 27 quarters since.
  • Victory Capital Management's Novavax position peaked at $13M in Q2 2021.
  • 267 funds tracked by Wall St. Rank held Novavax as of Q2 2026.

Based on Victory Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.